Trevor L. Wahlbrink is a General Partner at Ampersand Capital Partners. See sector focus and contact routes.
Trevor L. Wahlbrink is a General Partner at Ampersand Capital Partners, having joined the venture capital firm in 2012 after working as an Associate at investment banks Morgan Keegan and Covington Associates, where he focused on M&A for founder-owned healthcare companies. Ampersand’s investment thesis centers on early-stage healthcare ventures, particularly in biotechnology, medical devices, and digital health, with a primary focus on the United States. While specific check sizes and lead/follow behavior for Wahlbrink individually are not publicly detailed, Ampersand typically invests in Series A and B rounds as a lead investor in healthcare startups. His notable portfolio involvement includes board membership at Confluent Medical, Lexington Medical, MedPharm, Phosphorex, and Vantage MedTech, reflecting deep engagement with medical device services and outsourced pharma companies. Wahlbrink holds an M.S. and B.S. in Accounting and Finance from Boston College and is a CFA Charterholder, underscoring his analytical background in finance. There is no publicly available distinctive point of view or published writing by Wahlbrink beyond his professional bio and board roles
Every field above is read from the StartupFundraising investor directory — disclosed location, recorded investments and stated focus — and re-checked as filings arrive. Founders pair it with investors in Wellesley Hills when building a target list.
Investors like Trevor L. Wahlbrink · Full investor directory · Investor access · Company funding database